Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes

Fig. 2

Kaplan-Meier plots in the Luminal-A subtype. Kaplan-Meier estimates of DFS, LRFS and DRFS in patients with Luminal-A tumours (n = 156), according to high (solid green lines) and low (dashed blue lines) expression of PLCγ1, PLCγ1-pY1253 and PLCγ1-pY783. In this cohort, the patients showed distant relapse in 6% (5/91) PLCγ1Low and 14% (9/65) PLCγ1High, in 4% (4/90) PLCγ1-pY1253Low and 15% (10/66) PLCγ1-pY1253High, and in 3% (4/119) PLCγ1-pY783Low and 27% (10/37) PLCγ1-pY783High

Back to article page